In metastatic #breastcancer, sacituzumab govitecan given after trastuzumab deruxtecan was linked to ⬇️ PFS across all subtypes. Real-world data published in #JNCI show differences in outcomes by type. academic.oup.com/jnci/advance... @maryamlustberg.bsky.social

A big thank you once again to our dedicated Social Media Ambassadors for 2025: @maryamlustberg.bsky.social @darcyburbage.bsky.social @coffeemommy.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social Thank you for your insightful posting across the three days of #MASCC25!

Thank you!

Congratulations to @maryamlustberg.bsky.social named an inaugural @cancercaremascc.bsky.social Fellow during #mascc25!

Really appreciated the invite to speak from #MASCC25 and @maryamlustberg.bsky.social What a great conference! Amazing speakers on the #toxicities panel. #supportivecarematters #CanSky #OncoSky #IDSky

MASCC Introduced MASCC 2025 Social Media Ambassadors @cancercaremascc.bsky.social @darcyburbage.bsky.social @maryamlustberg.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social @coffeemommy.bsky.social oncodaily.com/blog/mascc-2... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd

Kudos and gratitude to the organizers, attendees, and fellow faculty members for today's Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment #MASCC25 @maryamlustberg.bsky.social @tingtingzhang.bsky.social @ericroeland.bsky.social @brueraeduardo.bsky.social

Grateful for the insights and discussions shared with the stellar panelists and engaged audience at #MASCC25 workshop for cancer treatment toxicities. @maryamlustberg.bsky.social @ericroeland.bsky.social @coffeemommy.bsky.social and Dr Eduardo Bruera with screenshot from @stage4kelly.bsky.social

Introducing our #MASCC25 Social Media Ambassadors on Bluesky! Follow them for daily highlights from across our scientific program: @maryamlustberg.bsky.social @darcyburbage.bsky.social @coffeemommy.bsky.social @bogda-koczwara.bsky.social @stage4kelly.bsky.social

Dr. Melissa Taylor presents data demonstrating the positive impact of ReX, a remote digital nurse app, to ⬇️ medication discontinuation and track #PROs at #ASCO25. meetings.asco.org/abstracts-pr... @maryamlustberg.bsky.social @oncoalert.bsky.social @yaleschoolofmed.bsky.social

@michael-jefford.bsky.social champions an allstar #survonc panel. 20 years from #IOM paper Lost in Transition. So much ground covered, so much yet to go. @oncoalert.bsky.social @weoncologists.bsky.social @pallonccop.bsky.social @fumikochino.bsky.social @maryamlustberg.bsky.social

Inspirational words on positioning yourself for success by these four women physician leaders! Sharing advice with early career women in oncology. Now we have the tools for success🛠️✨#ASCO2025 @maryamlustberg.bsky.social @drgattimays.bsky.social @yalecancer.bsky.social

Join us to discuss patient partnering in managing chronic toxicities of cancer treatment -with increasing burden from newer regimes on patients, doctors, and our healthcare systems. #medsky #palliative #supportivecare #oncosky #cancer #toxicities

1/2 Don’t miss our #MASCC25 workshop “Partnering with Patients in Managing Chronic Toxicities of Cancer and Its Treatment”, chaired by @maryamlustberg.bsky.social & @tingtingzhang.bsky.social With presentations from @ericroeland.bsky.social @brueraeduardo.bsky.social and @coffeemommy.bsky.social

Thank you @maryamlustberg.bsky.social for sharing updates from @cancercaremascc.bsky.social to the @pallonccop.bsky.social !! Looking forward to participating/promoting the many great programs and initiatives! #oncsky #oncologynursing

“Both hand cooling and compression were effective in preventing sensory #CIPN during taxane-based chemotherapy” #oncsky #oncologynursing @pallonccop.bsky.social @oncoalert.bsky.social jamanetwork.com/journals/jam...

We're heading to Chicago for the @theaacr.bsky.social Annual Meeting #AACR25! Follow along as we share highlights and news throughout the meeting. yalecancercenter.org/news-article... @yaleschoolofmed.bsky.social

A @yalecancer.bsky.social -led study examined chemotherapy-induced peripheral neuropathy #CIPN from clinical presentation, risk factors, + treatment strategies to impact of CIPN on QOL + patient experience. apm.amegroups.org/article/view... @yaleschoolofmed.bsky.social @maryamlustberg.bsky.social

Watch the recording from our recent webinar: Innovative Approaches in the Management of Bone Metastasis: Enhancing Patient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs) Prevention, and Biosimilars vimeo.com/1071779724?s... #SuppOnc @fatmabenabid.bsky.social

One week left to register for #MASCC25 at the early bird rate! The deadline is April 23, so be sure to register soon to take advantage of the discounted price. mascc.org/annualmeetin... #OncSky @oncoalert.bsky.social @maryamlustberg.bsky.social @andreasc.bsky.social @joannebowen.bsky.social

It's my first time going to @cancercaremascc.bsky.social!! Honored to be invited to speak about #financialToxicity and excited to see all of the amazing work being done in #supponc #survonc #pallonc 📆Register by 4/23/2025 to take advantage of the reduced "early bird" price for #MASCC25

The early bird registration deadline is coming up soon! Register by April 23, 2025 to take advantage of the reduced price for #MASCC25 mascc.org/annualmeetin... @oncoalert.bsky.social #OncSky @maryamlustberg.bsky.social @joannebowen.bsky.social @andreasc.bsky.social

Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early #BreastCancer, a discrete choice survey study recently published in the Breast Cancer Research and Treatment journal. 🔓https://pubmed.ncbi.nlm.nih.gov/39915434/ @elmayermd.bsky.social @maryamlustberg.bsky.social

Sounds like a great session @maryamlustberg.bsky.social!

Oncology HERE & NOW Webcast/Podcast Now Out, JOIN OncoAlert Faulty🚨 Dr. @elisaagostinetto.bsky.social 🇧🇪& Dr. @maryamlustberg.bsky.social 🇺🇸 as they dive into #BreastCancer and the use of adj CDK 4/6 inhibitors and more youtu.be/zw8vYd894jI Podcasts : buzzsprout.com/1324033/epis...

Congratulations to @craigmcrews.bsky.social, recipient of the 2025 Passano Award for his work leading to a new class of drugs—the #PROTAC concept—targeting protein degradation to treat #cancer and human diseases. @yaleschoolofmed.bsky.social

Thank you Infinite Strength & Roberta Lombardi for this wonderful conference #mbc #bcsm

One week left to submit your late-breaker abstracts for #MASCC25! Original research that has been completed after the regular abstract submission deadline is eligible for submission by March 12. mascc.org/annualmeetin... @oncoalert.bsky.social @joannebowen.bsky.social @maryamlustberg.bsky.social

Congratulations to the 7 members of @yalecancer.bsky.social receiving Blavatnik Awards: Dr. Demetrios Braddock @yalepathology.bsky.social; @craigmcrews.bsky.social; Dr. Seth Herzon; Dr. Richard Kibbey; Dr. Carrie Lucas; Dr. Markus Müschen; and Dr. Martin Schwartz. ventures.yale.edu/news/blavatn...

If you provide care to people with cancer in any capacity, we want to understand your experience with MASCC Guidelines. Please complete this short survey by March 14: www.surveymonkey.com/r/QL2HWGY #OncSky @oncoalert.bsky.social @maryamlustberg.bsky.social @europeancancer.bsky.social

With treatments for chemotherapy-induced peripheral #neuropathy having limited effectiveness, most pts in a recent study were likely to try non-guideline recs or relied on the Internet + other pts for non-prescribed solutions. pubmed.ncbi.nlm.nih.gov/39899120/ @maryamlustberg.bsky.social

✅ A highlight of last year was getting to present on a panel with Dr. Maura Berry and @maryamlustberg.bsky.social at #BrownUniversity 🌍 The Collaboration for Outcomes Using Social Media in Oncology (COSMO) held its second Conference on Social Media in Oncology in Providence #AYACSM #BCSM #OncSky

A survey showed pts with early-stage #breastcancer placed ⬆️ importance on efficacy and ⬇️ risk of symptomatic adverse events over other attributes when making treatment choices in the adjuvant setting. pubmed.ncbi.nlm.nih.gov/39915434/ @maryamlustberg.bsky.social @yaleschoolofmed.bsky.social

If you provide care to people with cancer in any capacity, we want to understand your experience with MASCC Guidelines.    Please complete this short survey by March 14: www.surveymonkey.com/r/QL2HWGY #OncSky @oncoalert.bsky.social @maryamlustberg.bsky.social @europeancancer.bsky.social

The final webinar in our Post-San Antonio Breast Cancer Symposium (#SABCS) will discuss New Treatment Options for #MetastaticBreastCancer. Join host @maryamlustberg.bsky.social and Dr. Adriana Kahn tonight at 6pm. RSVP: bit.ly/40ffiVM #bcsm @yaleschoolofmed.bsky.social

Impact of breast cancer trearment on fertility in link.springer.com/article/10.1... @oncoalert.bsky.social @clevelandclinic.bsky.social

Thank you for posting. Impact across the nation will be unprecedented

Don’t miss this new publication from our Neurological Complications Study Group: Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy link.springer.com/article/10.1... #SuppOnc

Recognizing the brilliant #WomenInMedicine today 2/3/25 who continue to persevere, break glass ceilings and improve healthcare #NWPD25 #IamBlackwell @quirogad.bsky.social @aryaroy.bsky.social @nerealliamd.bsky.social @drsgraff.bsky.social @drsarahsammons.bsky.social @maryamlustberg.bsky.social

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment oncodaily.com/insight/234405 #BreastCancer #Cancer #FDA #CancerCare #OncoDaily #Oncology #TheDESTINY-04Trial #TrastuzumabDeruxtecan #Medicine #Health

Where is the wisdom we have lost in knowledge? Where is the knowledge we have lost in information? T.S Eliot The Rock (1934)

Join us for the 5th Annual OncoAlert Colloquium, taking place free and online from Feb 3 – 9. MASCC is pleased to be hosting two sessions on Feb 4 dedicated to supportive care. Learn more or register here: oncoalert.m-pages.com/rnaYzs/the-5... #SuppOnc @maryamlustberg.bsky.social

We are thrilled to share the amazing presenters we have assembled for our MBC conference on March 8th in New Haven, CT. Register here: mbcc2025.givesmart.com @maryamlustberg.bsky.social @lizoriordan.bsky.social @marthacarlson.bsky.social @itsnotpink.bsky.social @drsarahsammons.bsky.social

Crowdsourcing ideas for a work retreat that you loved and enjoyed ( no matter how out there …) Feel free to share

The Infinite Strength Annual Gala is our largest event of the year and we are so thrilled to announce our keynotes @maryamlustberg.bsky.social @drsarahsammons.bsky.social @markrobsonmd.medsky.social and Robert Legare. Tickets become available Feb. 1 #bcsm

@cancercaremascc.bsky.social @maryamlustberg.bsky.social @drjonlim.bsky.social link.springer.com/article/10.1...

Register: Yale’s Post-San Antonio Breast Cancer Symposium #SABCS24 #CME webinars: 🔹Jan. 30, 6pm: Advances in #breastcancer care 🔹Feb. 6, 6pm: Advances in systemic therapy options for early-stage breast cancer 🔹Feb. 13, 6pm: New treatments for #mbc RSVP➡️ bit.ly/40ffiVM @maryamlustberg.bsky.social

Yale Department of Internal Medicine – New Professors in the Department of Internal Medicine @maryamlustberg.bsky.social @yaleschoolofmed.bsky.social oncodaily.com/blog/yale225... #Cancer #OncoDaily #Oncology #Medicine #Health